Correlation Between Equillium and TNF Pharmaceuticals,

Can any of the company-specific risk be diversified away by investing in both Equillium and TNF Pharmaceuticals, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Equillium and TNF Pharmaceuticals, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Equillium and TNF Pharmaceuticals,, you can compare the effects of market volatilities on Equillium and TNF Pharmaceuticals, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Equillium with a short position of TNF Pharmaceuticals,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Equillium and TNF Pharmaceuticals,.

Diversification Opportunities for Equillium and TNF Pharmaceuticals,

0.66

Correlation Coefficient

Equillium  TNF Pharmaceuticals,

Poor diversification

The 3 months correlation between Equillium and TNF is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Equillium and TNF Pharmaceuticals, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on TNF Pharmaceuticals, and Equillium is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Equillium are associated (or correlated) with TNF Pharmaceuticals,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of TNF Pharmaceuticals, has no effect on the direction of Equillium i.e., Equillium and TNF Pharmaceuticals, go up and down completely randomly.

Pair Corralation between Equillium and TNF Pharmaceuticals,

Allowing for the 90-day total investment horizon Equillium is expected to under-perform the TNF Pharmaceuticals,. But the stock apears to be less risky and, when comparing its historical volatility, Equillium is 2.44 times less risky than TNF Pharmaceuticals,. The stock trades about -0.22 of its potential returns per unit of risk. The TNF Pharmaceuticals, is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  140.00  in TNF Pharmaceuticals, on September 24, 2024 and sell it today you would lose (4.00) from holding TNF Pharmaceuticals, or give up 2.86% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Equillium  vs.  TNF Pharmaceuticals,

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest unsteady performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

TNF Pharmaceuticals,

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in TNF Pharmaceuticals, are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady technical and fundamental indicators, TNF Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Equillium and TNF Pharmaceuticals,

The main advantage of trading using opposite Equillium and TNF Pharmaceuticals, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Equillium position performs unexpectedly, TNF Pharmaceuticals, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TNF Pharmaceuticals, will offset losses from the drop in TNF Pharmaceuticals,'s long position.

The idea behind Equillium and TNF Pharmaceuticals, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.